Zymeworks (ZYME) Tops Q1 EPS by 48c

Zymeworks (NYSE: ZYME) reported Q1 EPS of ($1.19), $0.48 better than the analyst estimate of ($1.67). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $3.47 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• Pfizer lung cancer drug misses survival goal in Phase 3 trial